Friday, February 26, 2010

An article on Natural Killer Cell Development in Mice during Ontogeny

-Ontogeny:The origin and development of an individual organism from embryo to adult. Also called ontogenesis.(dictionary.com)
-Natural Killer Cells:
a large granular lymphocyte capable of killing a tumor or microbial cell without prior exposure to the target cell andwithout having it presented with or marked by a histocompatibility antigen called also NK cell (medical dictionary, dictionary.com)

NK cells

Unique features of NK cell development during ontogeny revealed in studies of RAG-1-deficient mice

Benedict J Chambers1 and Hans-Gustaf Ljunggren1

1Department of Medicine, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm 141 86, Sweden. E-mail: hans-gustaf.ljunggren@ki.se


Natural killer (NK) cells link early innate immune responses with adaptive immune responses. ‘Adaptive’ immune cells, that is, the T- and B-lymphocytes, express clonally distributed receptors, the expression of which is dependent on the recombination activation genes-1 (RAG-1) and RAG-2. In the absence of RAG-1 and/or RAG-2 proteins, T- and B-cell receptors cannot be formed and the cells fail to undergo normal development.1 In contrast, NK cells are equipped with a set of germline-encoded receptors whose expression is not dependent on the RAG-1 and/or RAG-2 proteins. Adult Rag-1- and Rag-2-deficient mice have been thought to have virtually normal numbers of NK cells with no general functional deficiency.2 However, Andrews and Smyth3 now, on careful analysis, observed marked differences in accumulation of NK cell subsets in different organs of neonatal Rag-1-deficient mice compared with corresponding wild-type mice. Importantly, these new observations reveal interesting insights into organ-specific NK cell development during ontogeny in mice.
What led Andrews and Smyth to the present studies was the previous identification of four discrete subsets of mouse NK cells based on analysis of CD27 and CD11b expression.4 The most immature subset is CD27lo/CD11b− cells, followed by CD27hi/CD11b−, CD27hi/CD11bhi and CD27lo/CD11bhi subsets. The CD27hi/CD11bhi subset of NK cells exhibits a profound cytokine-producing capacity, whereas the CD27lo/CD11bhi subset represents a terminally mature subset with high expression of major histocompatibility complex class I-recognizing Ly49 molecules. On the basis of this division of murine NK cell subsets, Andrews and Smyth set out to characterize NK cells in different organs during ontogeny in C57BL/6 mice. They found that NK cells in the bone marrow, spleen and lung of neonatal mice exist as immature CD27hi/CD11lo cells. The first appearance of mature CD27lo/CD11bhi cells in these organs occurs at 3 weeks of age and maturation is complete by 8 weeks of age. In contrast, they found, strikingly, that maturation of liver NK cells is ‘essentially finished’ by 2 weeks of age.
In the course of these studies, they made the interesting observation that patterns of NK cell subsets were altered in Rag-1-deficient mice compared with wild-type mice. Bone marrow and spleen NK cells were absent in neonatal Rag-1-deficient mice, and an overrepresentation of a precursor (CD27lo/CD11b−) NK cell subset was found in the bone marrow of neonatal Rag-1-deficient mice.3 These data argue for a role of RAG-1 in NK cell development. However, as Rag-1-deficient mice lack T and B cells, the possibility that the effects observed could be (in part) an indirect consequence of the absence of T and/or B cells cannot be excluded. Although the authors do not exclude this possibility, they provide indirect evidence against it. NK cell development in mice lacking either normal T cells, NKT cells or B cells did not mimic the phenotype observed in Rag-1-deficient mice.3 These results suggest that the absence of isolated subsets of adaptive immune cells (T, NKT or B cells) in Rag-1-deficient mice is not responsible for the absence of NK cells in the bone marrow and spleen during early ontogeny. Similarly, the overrepresentation of immature NK cells in the bone marrow of Rag-1-deficient mice cannot easily be explained by the absence of adaptive immune cells. This observation led Andrews and Smyth to suggest that the RAG-1 protein may regulate NK cell development in the bone marrow but not in the liver. In other words, NK cell development may occur independently between the bone marrow and liver as a possible consequence of differential precursor development, which is RAG-1-dependent (Figure 1). The present findings thus highlight the liver as a possible independent source of NK cells, generating an independent pool of NK cells with specific characteristics.5, 6
Figure 1.










NK cell development may occur independently in the bone marrow and in the liver during ontogeny as a consequence of precursor-development dependence on RAG-1. The present findings highlight the liver as a possible source of RAG-1-independent NK cells, generating a pool of NK cells with specific characteristics. In the absence of bone marrow-derived NK cells, such as in neonatal RAG-1-deficient mice, liver-derived NK cells may seed other organs including the bone marrow and spleen.Full figure and legend (122K)
Several important points are raised in this study. One is that full maturation of the NK cells does not occur in most organs until 8 weeks of age. This is of particular importance as several studies with, for example, new strains of genetically altered mice are often analyzed early in life for logistic and other related reasons. Andrews and Smyth bring up the possibility that studies on NK cells in mice should be standardized between laboratories and conducted on mice that are at least 8 weeks of age. This argument is indeed very well made. As pointed out, the present findings also bear relevance for vaccination of young mice, particularly in settings in which NK cells may influence the outcome.7
The present data suggest the possibility that RAG-1 might have a more direct role in NK cell development. It is not, however, easy to envisage what this role would be, or how it would work. As RAG transcripts are not detected in mature NK cells,8 a role for RAG in NK cell development must occur during linage commitment, as speculated by Andrews and Smyth.3 Studies have demonstrated that RAG-1/V(D)J activity occurs in lymphoid-primed progenitors, which, on transfer, can give rise to NK cells.9, 10 Given that most conventional NK cells in the bone marrow derive from these precursors,11 Andrews and Smyth reason that it is perhaps not surprising that NK cells cannot be detected in the bone marrow of neonatal mice.3 In contrast to the bone marrow, Rag-1-expression in fetal liver progenitors is not restricted to cells of the lymphoid lineage,12 suggesting that fetal lymphopoiesis is different in the liver than in the bone marrow. Accumulation of an immature (CD27lo/CD11b−) precursor population into the bone marrow of Rag-1-deficient mice indicates that liver NK cell precursors may seed into the other organs to compensate for the absence of bone marrow-derived NK cells. In support of this notion, Andrews and Smyth observed that accumulation of total and terminally mature NK cells in the bone marrow and spleen of Rag-1-deficient mice occurs ‘identically’ to that observed in the liver.3 In conclusion, the present findings suggest that NK cell development in the absence of RAG-1 is altered significantly, and raise the interesting suggestion of an accumulation of liver-derived NK cells in other organs. These observations should encourage further studies with respect to NK cell development during ontogeny.

Immunology and Cell Biology (2010) 88, 105–106; doi:10.1038/icb.2009.103; published online 15 December 2009

References

Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869–877. Article PubMed ISI ChemPort
Mombaerts P, Mizoguchi E, Ljunggren HG, Iacomini J, Ishikawa H, Wang L et al. Peripheral lymphoid development and function in TCR mutant mice. Int Immunol 1994; 6: 1061–1070. Article PubMed ISI ChemPort
Andrews DM, Smyth MJ. A potential role for RAG-1 in NK cell development revealed by analysis of NK cells during ontogeny. Immunol and Cell Biol (e-pub ahead of print 1 December 2009).

Sunday, February 21, 2010

Sickled Cell Disease and the Immune System!!!

This past Thursday, 2/18/10, I had to present a class project for my Immunology class. The project topic had to be something about immunology and with the presentation we had to make a model to represent our topic. My topic was Sickled Cell Anemia/ Sickled Cell Disease,(SCD), and for my model I baked a red velvet cake and designed two cells out of it, one being a normal Red Blood Cell, (RBC), and the other a sickled shape RBC. While developing this project I knew this disease had something to do with immunology but I wasn't sure how so I decided to do a little investigative research to receive information allowing me to link SCD to immunology! In this blog you will be informed of my findings so that you will also know why such a serious disease as SCD has an impact on our immune system!







Sickled Cell Disease


A genetic trait that confers resistance to maleria disease but causes a reduction in the number and effeciency of red blood cells by reducing the oxygen-binding affinity or hemoglobin.





What does SCD do?


SCD causes many infections within young children and continues to threaten them with infection as they get older. Those who have SCD are more likely to suffer from pneumonia, gallbladder infpammation, bone infections and, urinary tract infections. It also causes disease of the kidneys, liver and, lungs. Organ transplants are not uncommon among SCD patients because due to the inability to transport oxygen in the blood properly organ failure is common. One major organ that is often effected is the spleen.








How does SCD relate to the Immune System?
Google images

The spleen is a major organ of the immune system that filters the blood by cleaning out invading bacteria with its lymphatic cells such as B cells which bind to the bacteria and macrophages that ingest and kill the bacteria. Not all bacteria present such an easy process of elimination. Some bacteria are encapsulated and require opsonization which is a process of coting the bacteria with important immune factors within the blood to increase the ability of the encapsulated bacteria to be phagocytosed. Because this opsonizing porcess uses immune cells within the bloodstream and the bloodstream in SCD does not work properly, opsonization is decreased and many bacterial infections invade the immune system of those with SCD. With SCD the blood does not flow well within the tiny blood vessels of the spleen and can become clogged with these sickled shape cells, cutting off circulation and killing the spleen. The death of the spleen takes away the ability for opsonization which occurs with even flowing red blood cells and the immune cells within the blood.

SOURCES
-All images from google.com
- Madigan M T. Brock Biology of Microorganisms. Upper Saddle River (NJ): Pearson Printice Hall; 2006. 991 p.
- Kindt T J. Kuby Immunology. New York (NY): Sara Tenney W.H. Freeman and Company; 2007. 574 p.
-http://www.drspock.com/article/0,1510,5112,00.html

Friday, February 5, 2010

Diseases of the Immune System!!!

A FEW COMMON IMMUNE DISEASES

Asthma: A chronic disease that acts on the airways causing them to swell or become sore from inflammation caused by an immune response to an allergic reaction.Distinguished as an autoimmune disease

Mediterranean fever: Characterized by a series of fevers and inflammation. Affects the abdomen and lungs

Crohn's disease: An inflammatory bowel disease that infects the intestines may cause cramping, fever, fatigue, and loss of appetite.

Autoimmune polyglandular syndrome: characterized as an autoimmune disease with multiple endocrine gland insufficiencies.

Burkitt lymphoma: Characterized as rapid growth and swelling in the lymph nodes

Diabetes, type 1: Usually diagnosed in children, insulin-dependent. Without enough insulin glucose is built up within the bloodstream not allowing the body to use glucose for energy.

DiGeorge syndrome: An autoimmune disease that affects the thymus which then affects Tcell production.

Leukemia, chronic myeloid: A cancer that grows slowly with in the bone marrow with the over production of white blood cells but irregular blood cells that don't function correctly.


Each disease is briefly discussed and I look forward to further investigation!